Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Endocrinology | Neurology
Disease Category: Diabetic Neuropathy
Trial Information
Painful Diabetic Peripheral Neuropathy
We are conducting a clinical research study for volunteers diagnosed with Diabetes (Type 1 or 2) experiencing painful neuropathy for at least 6 months. This study lasts 18-23 weeks with up to 9 clinic visits.
Study Criteria:
- Age 18-70
- Diagnosed with Type 1 or 2 Diabetes
- Presence of pain due to Diabetic peripheral neuropathy for at least 6 months
- Stable blood glucose for at least 3 months
- No presence of other painful conditions that could affect the assessment of the pain due to DPN such as peripheral vascular disease, fibromyalgia, etc. or amputations due to diabetes.
- No previous history of taking pregabalin (Lyrica) for any reason and must be willing to wash out of all analgesic (pain) medications used for DPN.Allergic or adverse reaction to gabapentin (Neurotin, pregabalin (Lyrica) or acetaminophen (Tylenol).
- Cannot have failed previous adequate trials with at least 2 of the following: gabapentin (Neurotin), pregabalin (Lyrica) or duloxetine (Cymbalta)
- BMI (body mass index) must be 40 or less
- No history of severe psychiatric disorder, seizure disorder or any procedures (gastric bypass) that could affect absorption or metabolism
- No investigational drug within 30 days
- No pregnant or lactating women
- No drug or alcohol abuse in the past 5 years
If eligible, you will receive investigational drug and study-related medical care at no cost. Reimbursement for time and travel may also be available.
For additional information about this study or to enroll, visit our website:
www.clinicaltrialsinc.com
Contact:
Lauren Landers
Clinical Trials, Inc.
Two Lile Court, Suite 100
Little Rock, AR 72205
Telephone: 501-227-6179
Fax: 501-221-3426
Lauren Landers
Clinical Trials, Inc.
Two Lile Court, Suite 100
Little Rock, AR 72205
Phone: 501-227-6179
Fax: 501-221-3426
EMail: llanders@clinicaltrialsinc.com
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
